A detailed history of Deutsche Bank Ag\ transactions in Poseida Therapeutics, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 31,868 shares of PSTX stock, worth $301,152. This represents 0.0% of its overall portfolio holdings.

Number of Shares
31,868
Previous 24,275 31.28%
Holding current value
$301,152
Previous $70,000 30.0%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$2.7 - $4.04 $20,501 - $30,675
7,593 Added 31.28%
31,868 $91,000
Q2 2024

Aug 14, 2024

SELL
$2.0 - $3.46 $10,752 - $18,600
-5,376 Reduced 18.13%
24,275 $70,000
Q1 2024

May 15, 2024

BUY
$2.76 - $4.13 $81,836 - $122,458
29,651 New
29,651 $94,000
Q3 2023

Nov 09, 2023

BUY
$1.62 - $2.79 $58,125 - $100,105
35,880 New
35,880 $85,000
Q2 2022

Aug 11, 2022

SELL
$1.87 - $5.0 $29,207 - $78,095
-15,619 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$3.22 - $7.04 $5,982 - $13,080
-1,858 Reduced 10.63%
15,619 $70,000
Q4 2021

Feb 11, 2022

BUY
$6.23 - $7.6 $5,818 - $7,098
934 Added 5.65%
17,477 $119,000
Q3 2021

Nov 04, 2021

SELL
$7.09 - $10.71 $3,771 - $5,697
-532 Reduced 3.12%
16,543 $121,000
Q2 2021

Aug 11, 2021

SELL
$7.96 - $10.07 $39,004 - $49,343
-4,900 Reduced 22.3%
17,075 $171,000
Q1 2021

May 13, 2021

BUY
$8.51 - $11.91 $96,562 - $135,142
11,347 Added 106.77%
21,975 $209,000
Q4 2020

Feb 16, 2021

BUY
$8.29 - $11.7 $32,297 - $45,583
3,896 Added 57.87%
10,628 $117,000
Q3 2020

Nov 12, 2020

BUY
$8.09 - $16.25 $54,461 - $109,395
6,732 New
6,732 $60,000

Others Institutions Holding PSTX

About Poseida Therapeutics, Inc.


  • Ticker PSTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 85,775,600
  • Market Cap $811M
  • Description
  • Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...
More about PSTX
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.